SMART IMMUNE
French tech company | Builders Republic
About
Clinical-stage biotech developing ProTcell, a T-cell progenitor therapy platform that uses the patient's own thymus to rebuild the immune system — with lead candidate SMART101 in trials for blood cancers and immune deficiencies. Spin-off of Institut Imagine.
Key facts
- Status
- Morte
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2017
- City
- PARIS
- Region
- IDF
- Legal name
- SMART IMMUNE (SMART IMMUNE)
- SIREN
- 830784062
- Tracked rounds
- 1
- Amount raised
- 1.0 M€ raised since 2020
Funding rounds
- Seed — 2023
Investors
- Fondation Bill et Melinda Gates
Notes
Morte / liquidation judiciaire (30/06/2025), après redressement ouvert le 06/03/2025 (cessation de paiements 24/12/2024)